Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
2002 Standout
Thromboembolic Disease after Total Hip Arthroplasty
2006
Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".
1996
Evaluation of aspirin metabolites as inhibitors of hypoxia-inducible factor hydroxylases
2008 StandoutNobel
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Aspirin as an Antiplatelet Drug
1994
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Calibrated Automated Thrombin Generation Measurement in Clotting Plasma
2003 Standout
Fatal Pulmonary Embolism after Bariatric Operations for Morbid Obesity: A 24-Year Retrospective Analysis
2003
Perioperative Management of Antithrombotic Therapy
2012 Standout
New Antithrombotic Drugs
2012
Platelet-Active Drugs
1998
The role of platelets in the pathophysiology of asthma
2007
Platelet Activation and Atherothrombosis
2007 Standout
Antiplatelet Drugs
2008
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Prevention of Venous Thromboembolism
2004 Standout
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
2011 Standout
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2
1996 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Does withholding aspirin for one week reduce the risk of post‐sphincterotomy bleeding?
2002
Prevention of Venous Thromboembolism
2008 Standout
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
1998 Standout
Asthma during pregnancy: mechanisms and treatment implications
2005
Platelet-Active Drugs
2001
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
2004
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
Cyclooxygenases: Structural, Cellular, and Molecular Biology
2000 Standout
The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum
2011 Standout
Aspirin Dose in Stroke Prevention
1996
Adverse events associated with ERCP
2016 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease
2003
Aspirin and Other Platelet-Active Drugs
1992
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
A meta-analysis of randomized controlled trials
2019 Standout
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy
2012
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Antithrombotic Therapy for Cerebrovascular Disorders
1995
Works of Marek Krzanowski being referenced
Coronary flow reserve and exercise capacity in hypertrophic cardiomyopathy
1996
Bleeding Time and PAF-Acether-Induced Platelet Aggregation in Atopy
1987
Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis
2003
Verapamil improves the pacing-induced vasodilatation in symptomatic patients with hypertrophic cardiomyopathy
2002
Delayed generation of thrombin in clotting blood of atopic patients with hayfever and asthma
1991
Antiplatelet drugs and generation of thrombin in clotting blood
1992